|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 46 found articles
| Title: |
A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patients with follicular lymphoma |
| Author: |
Morschhauser, F. Recher, C. Milpied, N. Gressin, R. Salles, G. Brice, P. Vey, N. Haioun, C. Colombat, P. Rossi, J.F. Deconinck, E. Lazreg, F. Bergougnoux, L. Delsol, G. Attal, M. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 23 () nr. 10 pages 2687-2695 |
| Year: |
2012 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 46 found articles
| << previous | next >> |